Overcoming resistance to checkpoint blockade therapy by targeting PI3Kγ in myeloid cells
Parker Institute for Cancer Immunotherapy · Swim Across America · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
858
total citations
- FWCI
- 38.36
- Percentile
- 100%
- References
- 26
Citations per year
Authors
24- ODOlivier De Henau
Parker Institute for Cancer Immunotherapy, Swim Across America, Memorial Sloan Kettering Cancer Center
- MRMatthew Rausch
Infinity Pharmaceuticals (United States)
- DADavid A. Winkler
Infinity Pharmaceuticals (United States)
- LFLuís Felipe Campesato
Swim Across America, Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy
- CLCailian Liu
Memorial Sloan Kettering Cancer Center, Parker Institute for Cancer Immunotherapy, Swim Across America
Topics & keywords
Topics
Keywords
- Cancer research
- Immunotherapy
- Immune checkpoint
- Immune system
- Myeloid
- Tumor microenvironment
- PI3K/AKT/mTOR pathway
- Cytotoxic T cell
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.